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Open access unIntroduction
CA 125 is a high molecular weight glycoprotein and is the most
useful tumor marker for epithelial ovarian carcinoma. In 1981, the an-
tigen CA‐125 was identiﬁed by Bast et al. through the use of monoclo-
nal antibodies raised against cells derived from the ovarian cancer cell
line OVAL 433 (Shiau et al., 2003). Many benign conditions like the
pelvic inﬂammatory disease, endometriosis, uterine ﬁbroids etc.
may also give rise to moderate elevation of serum CA 125 (Jacobs
and Bast, 1989). The most common benign gynecological conditions
associated with high serum CA 125 are ovarian endometrioma and
deeply inﬁltrating endometriosis (Shiau et al., 2003).
We describe here a case with a very high and persistent level of
serum CA 125 following rupture of the right ovarian endometrioma
which responded to right salpingo-oopherectomy and Danazol.
Case report
A 40 year old (gravid 0, para 3) woman presented to our gynecolog-
ical outpatient department with moderate to severe pain of the abdo-
men for the last 24 h without any associated symptoms. Her menstrualGIMS, Raibareily Road, Lucknow‐226014,
anjus@hotmail.com (A.K. Rani),
der CC BY-NC-ND license .cycle was regular with mild dysmenorrhea for the last 5 months and
was on D7 of her menstrual cycle. Her past obstetrical history which in-
cludes a three lower segment cesarean section revealed nogynecological
disorders. Her past medical history was unremarkable.
On examination, the patient was in minimal distress with stable
vital signs. Her lower abdomen was tender and bimanual pelvic ex-
amination revealed a normal sized uterus with a smooth and soft
right adnexal mass. Transvaginal ultrasonography showed a bulky
uterus with normal left adnexa. The right adnexal area had a mass
of 10.5×7 cm with homogenous hypoechoic tissue of low level ech-
oes within the ovary with moderate ascites. Computed tomography
(CT) scan of the abdomen and pelvis revealed a bilateral adnexal
mass with minimal ascites and without any lymphadenopathy. Her
routine investigations were normal except for mild anemia (Hb
8.6 g/dl). The relevant tumor markers for adnexal tumor were normal
except for CA 125, which was markedly elevated (9391 IU/ml).
High serum CA 125 level and the abdominal scan reports raised the
suspicion of ovarian malignancy and the patient was scheduled for ex-
ploratory laparotomy. On laparotomy, omentum and bowel loops were
stained with chocolate colored ﬂuid with two right ovarian cysts — one
ruptured and another unruptured. The uterus was bulky with endo-
metriotic implants on its posterior surface, and on the left ovary. Adhe-
sions were present in the pouch of Douglas and on the left ovary. The
right unruptured ovarian cyst ruptured during adhesiolysis and approxi-
mately 200 ml of thick ‘chocolate’ colored ﬂuid drained out. A frozen sec-
tion of the ovarian cyst tissue showed no evidence of malignancy.
Conservative surgery (right salpingo-oopherectomy) with peritoneal
lavage was done keeping her age in view. Her postoperative period
was uneventful and the histopathology conﬁrmed the diagnosis of
endometriosis.
There was a sharp decline in serum CA 125 level following surgery.
Danazol was given to the patient for 6 months. The serum CA 125
level came to normal after 4 months (Fig. 1).
Discussion
In 1981, CA‐125 was identiﬁed as an ovarian cancer antigen and
was investigated as a speciﬁc marker of ovarian malignancy. The ref-
erence value of 35 IU/ml was based on the pioneering work by Bast et
al. A serum CA 125 level of more than 200 U/ml is considered a posi-
tive criterion for differentiating malignant from benign pelvic masses
in premenopausal women younger than 50 years (Graham, 2008). It
Fig. 1. CA 125 concentration in serum following ruptured ovarian endometrioma. Day
‘0’ refers to the date of operation.
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is the probability that the abdomino-perineal mass is malignant.
Many benign conditionsmay cause a raised serumCA 125. Endome-
triosis is themost common benign lesionwhich gives rise to an elevated
level of serum CA 125. Endometriosis rarely gives rise to serum CA 125
of more than 100 IU/ml (Kauppila et al., 1988) and the highest value so
far reported with histologically conﬁrmed endometriosis is 9300 IU/ml
(Johansson et al., 1998). It is alsoworth noting that the elimination half‐
life of CA 125 is 4.5 days. The mechanism by which endometriosis may
elevate the serum CA 125 level is partly understood. It may be due to
many reasons and one could be the enlarged surface area of the endo-
metrial tissue which secretes CA 125. The CA 125 concentration in
cyst ﬂuid of an ovarian endometrioma is very high, but the thick walls
of the endometrioma prevents the large CA 125 glycoproteinmolecules
from reaching the peripheral circulation, although the block is not total
(Koninckx et al., 1992). In the present case, the spill of endometrioma
ﬂuid into the peritoneal cavity due to rupture of endometrioma leads
to a rapid increase in the serum CA 125 level.There is evidence that peritonealmesothelial cells are evenmore po-
tent than ovarian cancer cells in producing CA 125 (Zeimet et al., 1996).
The overﬂowof thick, ‘chocolate’ cystﬂuid in the peritoneal cavity causes
endometriosis‐induced peritoneal inﬂammation (Bouquet de Joliniere et
al., 1997)which leads to excess CA 125 in the circulation. In addition, su-
perﬁcial endometrial implants over the ovarymay secret CA 125 into the
peritoneal cavity which further gets reabsorbed slowly into the circula-
tion. The persistently high serum CA 125 level for more than 2 months
supports the concept that mesothelial cells of the peritoneum were the
most important source of CA 125 in the present case.
To conclude, very high serum CA 125 level does not necessarily in-
dicate ovarian malignancy. Rapidly rising and persistent levels may
be consistent with benign diseases like endometriosis.
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